|
WO2020239244A1
|
|
An inhaler for electronically supervised parenteral administration of a pharmaceutical composition
|
|
WO2020239243A1
|
|
Electronically supervised administration of a pharmaceutical composition
|
|
AU2019205093A1
|
|
3-phenyl-4-hexynoic acid derivatives as GPR40 agonists
|
|
EP3628313A1
|
|
Ketamine composition for use in a method of treatment of depression by pulmonary administration
|
|
WO2018206739A1
|
|
Pyrazole[1,5-a]pyrimidine derivatives as kinase jak inhibitors
|
|
EP3505157A1
|
|
Dry powder ketamine composition for pulmonary administration in treatment-resistant depression
|
|
WO2019097282A1
|
|
Isoindoline derivatives for the treatment of cns diseases
|
|
WO2016157091A1
|
|
7-(morpholin-4-yl)pyrazole[1,5-a]pyrimidine derivatives which are useful for the treatment of immune or inflammatory diseases or cancer
|
|
EP3145930A1
|
|
Fused triazole derivatives as phosphodiesterase 10a inhibitors
|
|
WO2015118434A1
|
|
PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS KINASE JAK-2 INHIBITORS
|
|
EA026782B1
|
|
PYRAZOLYLBENZO[d]IMIDAZOLE DERIVATIVES
|
|
WO2014024125A1
|
|
Pyrazolo[4,3-d]pyrimidin-7(6h)-one derivatives as pde9 inhibitors
|
|
WO2014020531A1
|
|
Imidazo[1,2-b]pyridazin-6-amine derivatives as kinase jak-2 inhibitors
|
|
WO2014016789A1
|
|
Pyrazolo[3,4-d]pyrimidin-4(5h)-one derivatives as pde9 inhibitors
|
